ZA976593B - Novel treatment - Google Patents

Novel treatment

Info

Publication number
ZA976593B
ZA976593B ZA976593A ZA976593A ZA976593B ZA 976593 B ZA976593 B ZA 976593B ZA 976593 A ZA976593 A ZA 976593A ZA 976593 A ZA976593 A ZA 976593A ZA 976593 B ZA976593 B ZA 976593B
Authority
ZA
South Africa
Prior art keywords
novel treatment
novel
treatment
Prior art date
Application number
ZA976593A
Other languages
English (en)
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA976593B publication Critical patent/ZA976593B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA976593A 1996-07-26 1997-07-24 Novel treatment ZA976593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment

Publications (1)

Publication Number Publication Date
ZA976593B true ZA976593B (en) 1999-01-25

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976593A ZA976593B (en) 1996-07-26 1997-07-24 Novel treatment

Country Status (19)

Country Link
EP (1) EP0936924A2 (pt)
JP (1) JP2000516924A (pt)
KR (1) KR20000029564A (pt)
CN (1) CN1230894A (pt)
AR (1) AR008083A1 (pt)
AU (1) AU725817B2 (pt)
BR (1) BR9710568A (pt)
CA (1) CA2261813A1 (pt)
CO (1) CO5031292A1 (pt)
CZ (1) CZ23799A3 (pt)
GB (1) GB9615767D0 (pt)
HU (1) HUP9903619A3 (pt)
IL (1) IL128219A0 (pt)
NO (1) NO990322L (pt)
NZ (1) NZ333813A (pt)
PL (1) PL331426A1 (pt)
TR (1) TR199900140T2 (pt)
WO (1) WO1998004289A2 (pt)
ZA (1) ZA976593B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6174882B1 (en) 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
WO2000054764A2 (en) * 1999-03-18 2000-09-21 Children's Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
EP1223939A1 (en) * 1999-05-19 2002-07-24 AstraZeneca AB Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
HUP9903619A2 (hu) 2000-10-28
HUP9903619A3 (en) 2001-03-28
NO990322L (no) 1999-03-24
PL331426A1 (en) 1999-07-19
WO1998004289A3 (en) 1998-03-19
KR20000029564A (ko) 2000-05-25
EP0936924A2 (en) 1999-08-25
CN1230894A (zh) 1999-10-06
WO1998004289A2 (en) 1998-02-05
CZ23799A3 (cs) 1999-06-16
CA2261813A1 (en) 1998-02-05
IL128219A0 (en) 1999-11-30
NO990322D0 (no) 1999-01-25
BR9710568A (pt) 1999-08-17
NZ333813A (en) 2000-07-28
GB9615767D0 (en) 1996-09-04
AU4297297A (en) 1998-02-20
CO5031292A1 (es) 2001-04-27
TR199900140T2 (xx) 1999-03-22
JP2000516924A (ja) 2000-12-19
AU725817B2 (en) 2000-10-19
AR008083A1 (es) 1999-12-09

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
GB9700899D0 (en) Novel treatment
GB9519033D0 (en) Treatment
GB9619492D0 (en) Novel treatment
GB9410512D0 (en) Novel treatment
ZA976593B (en) Novel treatment
GB9411635D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
GB2355006B (en) Materials treatment
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
GB9620085D0 (en) Cosmetic treatment
GB9721692D0 (en) Novel treatment
GB9614751D0 (en) Novel treatment
GB9604046D0 (en) Novel treatment
GB9619493D0 (en) Novel treatment
GB9616409D0 (en) Novel treatment
GB9616412D0 (en) Novel treatment
GB9616407D0 (en) Novel treatment
GB9616410D0 (en) Novel treatment
GB9616413D0 (en) Novel treatment
GB9625201D0 (en) Novel treatment
GB9616415D0 (en) Novel treatment
GB9616414D0 (en) Novel treatment
GB9616408D0 (en) Novel treatment